We help companies and governments transform the most complex parts of policy, market-shaping strategies, and conflict cases into actionable steps.
Assessing policy impacts and shaping policy change
We assist pharmaceutical companies, patient organisations and policymakers in devising and shaping policies using data-driven insights and economic analyses. We assess the impact of policy and regulatory changes on company pipelines, healthcare systems, and the economy. Based on this, we offer strategic advice on commercial decisions, policy choices, and advocacy positions. Our combination of rigorous data analysis and academic precision with clear, compelling narratives and actionable recommendations ensures our work is highly credible and impactful.
Supporting successful product launches and commercial strategies
We help global pharmaceutical companies develop optimal launch and pricing strategies, guiding innovative products from pipeline to commercial success. We demonstrate the burden of diseases and the value of medical innovations to policy, pricing, and reimbursement decision-makers through real-world evidence studies and budget impact assessments. We develop and advise on data and evidence strategies to ensure timely availability of the right evidence to support the value proposition of a medical innovation. Using game theory, quantitative modelling, and war gaming, we support companies in optimising their pricing strategies.
Navigating competition cases, litigation, and merger proceedings
With one of the largest competition economics teams in Europe, we bring extensive experience from high-profile competition and litigation cases in the pharmaceutical sector and collaborate closely with leading global law firms.
Our unique combination of competition economics and life sciences expertise within a single team provides a strong value proposition for clients engaging with the European Commission or national competition authorities.
